BACKGROUND: Although many different types of insulin delivery devices are currently available, there is no well-accepted, validated method to assess @entity1 satisfaction with these devices and their impact on quality of life and other @entity1 -reported outcomes. To address this problem, we developed the Insulin Device Satisfaction Survey (IDSS) and herein describe its construction and validation. We then examine how key @entity1 factors are associated with device satisfaction. MATERIALS AND METHODS: Items were developed from interviews with adults with @entity1723 ( @entity1723 ) (n=10) and @entity2175 ( @entity2175 ) using insulin (n=10), as well as eight healthcare professionals, leading to an initial pool of 32 items. Separate exploratory factor analyses (EFAs) were conducted with @entity1723 subjects (n=279) and insulin-using @entity2175 subjects (n=209). Construct validity was established with overall well-being (World Health Organization-5), @entity6 ( @entity6 Scale), @entity6 self-efficacy (Self-Efficacy for @entity6 Management Scale), and subscales from the Insulin Delivery System Rating Questionnaire. Regression analyses examined associations between total scale satisfaction and demographics, insulin adherence, clinical indicators, and device type (pump vs. nonpump users). RESULTS: The two EFAs resulted in a 14-item scale for @entity1723 subjects and a 12-item scale for @entity2175 subjects, with eight items common across both samples. The EFAs yielded three coherent, meaningful factors in each sample, accounting for 55.6% ( @entity1723 sample) and 64.1% ( @entity2175 sample) of the variance. Validity was established by significant correlations with all criterion variables. For both samples, higher IDSS scores were significantly associated with better glycemic control and greater insulin adherence and pump use. For @entity2175 subjects only, IDDS scores were significantly linked to fewer long-term complications, fewer low blood @entity413 readings, and older age. CONCLUSIONS: The IDSS is a reliable, valid measure of insulin device satisfaction in both its @entity1723 form and T2 form. It provides a comprehensive profile of sources of device satisfaction for use in clinical care and research.

Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in XXXX with Type 1 and Type 2 @entity6 .

@entity1 :: ('9606', 'Species') :: ['patient'] @entity2175 :: ('MESH:D003924', 'Disease') :: ['type 2 diabetes', 'T2D'] @entity6 :: ('MESH:D003920', 'Disease') :: ['Diabetes', 'diabetes distress', 'Diabetes Distress', 'diabetes'] @entity1723 :: ('MESH:D003922', 'Disease') :: ['T1D', 'type 1 diabetes'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose']
@entity1 :: (9606,Species) :: ['Patients']
